This inventor holds 6 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Cyclacel Limited, Darwin Discovery Limited, Arakis Ltd.. Active years: 1999-2021.
Company Filing History:
3 out of 56 
2 out of 90 
1 out of 3 Years Active: 1999-2021
Title: The Innovative Contributions of Benjamin Mark Skead
Introduction
Benjamin Mark Skead is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of chemistry, particularly in the development of purine derivatives. With a total of 6 patents to his name, Skead's work has implications in pharmaceuticals and anti-tumor treatments.
Latest Patents
Skead's latest patents include a process for preparing purine derivatives. This invention outlines a method that involves forming a reaction mixture with specific compounds and heating it to create a desired compound. Additionally, he has developed new crystalline forms of a purine derivative that exhibit excellent anti-tumor activity. These inventions not only advance scientific knowledge but also hold potential for medical applications.
Career Highlights
Throughout his career, Benjamin Mark Skead has worked with various companies, including Cyclacel Limited and Darwin Discovery Limited. His experience in these organizations has allowed him to collaborate on innovative projects and contribute to advancements in the field.
Collaborations
Some of his notable coworkers include Jonathan Charles Christian Atherton and Julian Scott Northen. Their collaborative efforts have further enriched the research and development landscape in which Skead operates.
Conclusion
Benjamin Mark Skead's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new pharmaceutical solutions.